How do you pay?

How to pay the least

Ask for the cash price

Thalomid

We didn’t find one.

  1. Ask your pharmacy for Thalomid’s cash price, and one or two other pharmacies too.
  2. Thalomid’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Bristol Myers Squibb Patient Assistance Foundation (BMSPAF). Or call 1-800-736-0003.

See if you qualify 

Compare every option

Question
Brand nameThalomid
Authorized genericthalidomide
Regular genericthalidomide
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Thalomid?
The original
–
–

Brand nameThe maker’s card

BMS Access Support Co-Pay Assistance Program

Savings card from Bristol Myers Squibb

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on bmsaccesssupport.com 

Or call 1-800-861-0048.

In the maker’s words

“Eligible patients may pay as little as $0 per one-month supply, subject to a maximum benefit.”

From the maker’s offer on bmsaccesssupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Thalomid itself, from the same company, sold without the brand name, and usually for less. For now Thalomid is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says
  • THALOMID in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM).
  • THALOMID is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.

Source: the FDA label for Thalomid (Celgene Corporation), March 24, 2023. Full label on DailyMed 

Good to know